OQS
IMGN

Occudo Quantitative Strategies’s Immunogen Inc IMGN Stock Holding History

Occudo Quantitative Strategies’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-77,811
Closed -$350K – 1479
2022
Q2 		$350K Buy
+77,811
New +$338K 0.03% 737
2021
Q4 		– Sell
-10,869
Closed -$62K – 1296
2021
Q3 		$62K Buy
+10,869
New +$62.8K 0.01% 959
2021
Q1 		– Sell
-49,863
Closed -$322K – 964
2020
Q4 		$322K Buy
+49,863
New +$291K 0.1% 392

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Occudo Quantitative Strategies's IMGN Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 77,811 shares — an estimated $350K sold.

Occudo Quantitative Strategies first reported a position in IMGN in Q4 2020 and held it in 3 quarters. The position peaked at $350K in Q2 2022. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

  • Occudo Quantitative Strategies reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 77,811 Immunogen Inc shares in Q3 2022, an estimated $350K.
  • Occudo Quantitative Strategies first reported a position in Immunogen Inc in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Immunogen Inc position peaked at $350K in Q2 2022.
  • 222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.